Van den Mooter G - Search Results

1

Influence of the composition of in-vitro azo-reducing systems on the degradation kinetics of the model compound amaranth.

Maris B, Verheyden L, Samyn C, Augustijns P, Kinget R, Van den Mooter G. Maris B, et al. Among authors: van den mooter g. J Pharm Pharmacol. 2002 Feb;54(2):197-203. doi: 10.1211/0022357021778385. J Pharm Pharmacol. 2002. PMID: 11848283

2

The relation between swelling properties and enzymatic degradation of azo polymers designed for colon-specific drug delivery.

Van den Mooter G, Samyn C, Kinget R. Van den Mooter G, et al. Pharm Res. 1994 Dec;11(12):1737-41. doi: 10.1023/a:1018911316021. Pharm Res. 1994. PMID: 7899237

3

Use of azo polymers for colon-specific drug delivery.

Van den Mooter G, Maris B, Samyn C, Augustijns P, Kinget R. Van den Mooter G, et al. J Pharm Sci. 1997 Dec;86(12):1321-7. doi: 10.1021/js9702630. J Pharm Sci. 1997. PMID: 9423139 Review. No abstract available.

4

Synthesis and characterisation of inulin-azo hydrogels designed for colon targeting.

Maris B, Verheyden L, Van Reeth K, Samyn C, Augustijns P, Kinget R, Van den Mooter G. Maris B, et al. Among authors: van den mooter g, van reeth k. Int J Pharm. 2001 Feb 1;213(1-2):143-52. doi: 10.1016/s0378-5173(00)00654-2. Int J Pharm. 2001. PMID: 11165102

5

The in vitro evaluation of 'azo containing polysaccharide gels' for colon delivery.

Stubbe B, Maris B, Van den Mooter G, De Smedt SC, Demeester J. Stubbe B, et al. Among authors: van den mooter g. J Control Release. 2001 Jul 10;75(1-2):103-14. doi: 10.1016/s0168-3659(01)00367-4. J Control Release. 2001. PMID: 11451501

6

In vivo evaluation of a colon-specific drug delivery system: an absorption study of theophylline from capsules coated with azo polymers in rats.

Van den Mooter G, Samyn C, Kinget R. Van den Mooter G, et al. Pharm Res. 1995 Feb;12(2):244-7. doi: 10.1023/a:1016283027139. Pharm Res. 1995. PMID: 7784340

7

In vitro biodegradation study of acetyl and methyl inulins by Bifidobacteria and inulinase.

Damian F, Van den Mooter G, Samyn C, Kinget R. Damian F, et al. Among authors: van den mooter g. Eur J Pharm Biopharm. 1999 May;47(3):275-82. doi: 10.1016/s0939-6411(99)00007-7. Eur J Pharm Biopharm. 1999. PMID: 10382112

8

Inhibition of intestinal metabolism of the antiviral ester prodrug bis(POC)-PMPA by nature-identical fruit extracts as a strategy to enhance its oral absorption: an in vitro study.

Van Gelder J, Annaert P, Naesens L, De Clercq E, Van den Mooter G, Kinget R, Augustijns P. Van Gelder J, et al. Among authors: van den mooter g. Pharm Res. 1999 Jul;16(7):1035-40. doi: 10.1023/a:1018931631912. Pharm Res. 1999. PMID: 10450927

9

Safety assessment of selected cyclodextrins - effect on ciliary activity using a human cell suspension culture model exhibiting in vitro ciliogenesis.

Uchenna Agu R, Jorissen M, Willems T, Van den Mooter G, Kinget R, Verbeke N, Augustijns P. Uchenna Agu R, et al. Among authors: van den mooter g. Int J Pharm. 2000 Jan 5;193(2):219-26. doi: 10.1016/s0378-5173(99)00342-7. Int J Pharm. 2000. PMID: 10606785

10

Species-dependent and site-specific intestinal metabolism of ester prodrugs.

Van Gelder J, Shafiee M, De Clercq E, Penninckx F, Van den Mooter G, Kinget R, Augustijns P. Van Gelder J, et al. Among authors: van den mooter g. Int J Pharm. 2000 Sep 15;205(1-2):93-100. doi: 10.1016/s0378-5173(00)00507-x. Int J Pharm. 2000. PMID: 11000545

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters